Author:
Pilkington Victoria,Hughes Sophie L.,Pepperrell Toby,McCann Kaitlyn,Gotham Dzintars,Pozniak Anton L.,Hill Andrew
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference41 articles.
1. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults;Ruane;J Acquir Immune Defic Syndr,2013
2. Changes in kidney function associated with daily tenofovir disoproxil fumarate/emtricitabine for HIV preexposure prophylaxis use in the united states demonstration project;Tang;J Acquir Immune Defic Syndr,2017
3. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials;Gupta;AIDS,2019
4. Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?;Vitoria;J Int AIDS Soc,2016
5. Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV;Imaz;Expert Rev Anti Infect Ther,2017
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献